Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study.

Autor: Lodato, F.1 francesca.lodato@inwind.it, Azzaroli, F.1, Brillanti, S.1, Colecchia, A.1, Tam, M. R.1, Montagnani, M.1, Muratori, R.1, Giovanelli, S.1, Feletti, V.1, Bacchi Reggiani, M. L.2, Roda, E.1, Mazzella, G.1
Zdroj: Journal of Viral Hepatitis. Sep2005, Vol. 12 Issue 5, p536-542. 7p.
Databáze: Academic Search Ultimate